Global In Vivo and In Vitro DMPK and ADME Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo and In Vitro DMPK and ADME Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global In Vivo and In Vitro DMPK and ADME Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo and In Vitro DMPK and ADME Market Perspective (2020-2031)
2.2 Global In Vivo and In Vitro DMPK and ADME Growth Trends by Region
2.2.1 Global In Vivo and In Vitro DMPK and ADME Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vivo and In Vitro DMPK and ADME Historic Market Size by Region (2020-2025)
2.2.3 In Vivo and In Vitro DMPK and ADME Forecasted Market Size by Region (2026-2031)
2.3 In Vivo and In Vitro DMPK and ADME Market Dynamics
2.3.1 In Vivo and In Vitro DMPK and ADME Industry Trends
2.3.2 In Vivo and In Vitro DMPK and ADME Market Drivers
2.3.3 In Vivo and In Vitro DMPK and ADME Market Challenges
2.3.4 In Vivo and In Vitro DMPK and ADME Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo and In Vitro DMPK and ADME Players by Revenue
3.1.1 Global Top In Vivo and In Vitro DMPK and ADME Players by Revenue (2020-2025)
3.1.2 Global In Vivo and In Vitro DMPK and ADME Revenue Market Share by Players (2020-2025)
3.2 Global In Vivo and In Vitro DMPK and ADME Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vivo and In Vitro DMPK and ADME Revenue
3.4 Global In Vivo and In Vitro DMPK and ADME Market Concentration Ratio
3.4.1 Global In Vivo and In Vitro DMPK and ADME Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo and In Vitro DMPK and ADME Revenue in 2024
3.5 Global Key Players of In Vivo and In Vitro DMPK and ADME Head office and Area Served
3.6 Global Key Players of In Vivo and In Vitro DMPK and ADME, Product and Application
3.7 Global Key Players of In Vivo and In Vitro DMPK and ADME, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vivo and In Vitro DMPK and ADME Breakdown Data by Type
4.1 Global In Vivo and In Vitro DMPK and ADME Historic Market Size by Type (2020-2025)
4.2 Global In Vivo and In Vitro DMPK and ADME Forecasted Market Size by Type (2026-2031)
5 In Vivo and In Vitro DMPK and ADME Breakdown Data by Application
5.1 Global In Vivo and In Vitro DMPK and ADME Historic Market Size by Application (2020-2025)
5.2 Global In Vivo and In Vitro DMPK and ADME Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vivo and In Vitro DMPK and ADME Market Size (2020-2031)
6.2 North America In Vivo and In Vitro DMPK and ADME Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vivo and In Vitro DMPK and ADME Market Size by Country (2020-2025)
6.4 North America In Vivo and In Vitro DMPK and ADME Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo and In Vitro DMPK and ADME Market Size (2020-2031)
7.2 Europe In Vivo and In Vitro DMPK and ADME Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vivo and In Vitro DMPK and ADME Market Size by Country (2020-2025)
7.4 Europe In Vivo and In Vitro DMPK and ADME Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Size (2020-2031)
8.2 Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vivo and In Vitro DMPK and ADME Market Size (2020-2031)
9.2 Latin America In Vivo and In Vitro DMPK and ADME Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vivo and In Vitro DMPK and ADME Market Size by Country (2020-2025)
9.4 Latin America In Vivo and In Vitro DMPK and ADME Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Size (2020-2031)
10.2 Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River In Vivo and In Vitro DMPK and ADME Introduction
11.1.4 Charles River Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In Vivo and In Vitro DMPK and ADME Introduction
11.2.4 Labcorp Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.2.5 Labcorp Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON In Vivo and In Vitro DMPK and ADME Introduction
11.3.4 ICON Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.3.5 ICON Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Details
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health In Vivo and In Vitro DMPK and ADME Introduction
11.4.4 Syneos Health Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.4.5 Syneos Health Recent Development
11.5 Envigo
11.5.1 Envigo Company Details
11.5.2 Envigo Business Overview
11.5.3 Envigo In Vivo and In Vitro DMPK and ADME Introduction
11.5.4 Envigo Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.5.5 Envigo Recent Development
11.6 Curia
11.6.1 Curia Company Details
11.6.2 Curia Business Overview
11.6.3 Curia In Vivo and In Vitro DMPK and ADME Introduction
11.6.4 Curia Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.6.5 Curia Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec In Vivo and In Vitro DMPK and ADME Introduction
11.7.4 Evotec Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.7.5 Evotec Recent Development
11.8 Bioduro-Sundia
11.8.1 Bioduro-Sundia Company Details
11.8.2 Bioduro-Sundia Business Overview
11.8.3 Bioduro-Sundia In Vivo and In Vitro DMPK and ADME Introduction
11.8.4 Bioduro-Sundia Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.8.5 Bioduro-Sundia Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza In Vivo and In Vitro DMPK and ADME Introduction
11.9.4 Lonza Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.9.5 Lonza Recent Development
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Details
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec In Vivo and In Vitro DMPK and ADME Introduction
11.10.4 WuXi AppTec Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.10.5 WuXi AppTec Recent Development
11.11 IQVIA
11.11.1 IQVIA Company Details
11.11.2 IQVIA Business Overview
11.11.3 IQVIA In Vivo and In Vitro DMPK and ADME Introduction
11.11.4 IQVIA Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.11.5 IQVIA Recent Development
11.12 Tecan Group
11.12.1 Tecan Group Company Details
11.12.2 Tecan Group Business Overview
11.12.3 Tecan Group In Vivo and In Vitro DMPK and ADME Introduction
11.12.4 Tecan Group Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.12.5 Tecan Group Recent Development
11.13 Pharmaron
11.13.1 Pharmaron Company Details
11.13.2 Pharmaron Business Overview
11.13.3 Pharmaron In Vivo and In Vitro DMPK and ADME Introduction
11.13.4 Pharmaron Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.13.5 Pharmaron Recent Development
11.14 Shanghai Medicilon
11.14.1 Shanghai Medicilon Company Details
11.14.2 Shanghai Medicilon Business Overview
11.14.3 Shanghai Medicilon In Vivo and In Vitro DMPK and ADME Introduction
11.14.4 Shanghai Medicilon Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.14.5 Shanghai Medicilon Recent Development
11.15 ChemPartner
11.15.1 ChemPartner Company Details
11.15.2 ChemPartner Business Overview
11.15.3 ChemPartner In Vivo and In Vitro DMPK and ADME Introduction
11.15.4 ChemPartner Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.15.5 ChemPartner Recent Development
11.16 Joinn Laboratories
11.16.1 Joinn Laboratories Company Details
11.16.2 Joinn Laboratories Business Overview
11.16.3 Joinn Laboratories In Vivo and In Vitro DMPK and ADME Introduction
11.16.4 Joinn Laboratories Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.16.5 Joinn Laboratories Recent Development
11.17 RTI International
11.17.1 RTI International Company Details
11.17.2 RTI International Business Overview
11.17.3 RTI International In Vivo and In Vitro DMPK and ADME Introduction
11.17.4 RTI International Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.17.5 RTI International Recent Development
11.18 Eurofins Scientific
11.18.1 Eurofins Scientific Company Details
11.18.2 Eurofins Scientific Business Overview
11.18.3 Eurofins Scientific In Vivo and In Vitro DMPK and ADME Introduction
11.18.4 Eurofins Scientific Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.18.5 Eurofins Scientific Recent Development
11.19 Aragen Life Sciences
11.19.1 Aragen Life Sciences Company Details
11.19.2 Aragen Life Sciences Business Overview
11.19.3 Aragen Life Sciences In Vivo and In Vitro DMPK and ADME Introduction
11.19.4 Aragen Life Sciences Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.19.5 Aragen Life Sciences Recent Development
11.20 Sai Life Sciences
11.20.1 Sai Life Sciences Company Details
11.20.2 Sai Life Sciences Business Overview
11.20.3 Sai Life Sciences In Vivo and In Vitro DMPK and ADME Introduction
11.20.4 Sai Life Sciences Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
11.20.5 Sai Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global In Vivo and In Vitro DMPK and ADME Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecules
Table 3. Key Players of Biologics
Table 4. Global In Vivo and In Vitro DMPK and ADME Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global In Vivo and In Vitro DMPK and ADME Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global In Vivo and In Vitro DMPK and ADME Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global In Vivo and In Vitro DMPK and ADME Market Share by Region (2020-2025)
Table 8. Global In Vivo and In Vitro DMPK and ADME Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global In Vivo and In Vitro DMPK and ADME Market Share by Region (2026-2031)
Table 10. In Vivo and In Vitro DMPK and ADME Market Trends
Table 11. In Vivo and In Vitro DMPK and ADME Market Drivers
Table 12. In Vivo and In Vitro DMPK and ADME Market Challenges
Table 13. In Vivo and In Vitro DMPK and ADME Market Restraints
Table 14. Global In Vivo and In Vitro DMPK and ADME Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global In Vivo and In Vitro DMPK and ADME Market Share by Players (2020-2025)
Table 16. Global Top In Vivo and In Vitro DMPK and ADME Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo and In Vitro DMPK and ADME as of 2024)
Table 17. Ranking of Global Top In Vivo and In Vitro DMPK and ADME Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by In Vivo and In Vitro DMPK and ADME Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of In Vivo and In Vitro DMPK and ADME, Headquarters and Area Served
Table 20. Global Key Players of In Vivo and In Vitro DMPK and ADME, Product and Application
Table 21. Global Key Players of In Vivo and In Vitro DMPK and ADME, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In Vivo and In Vitro DMPK and ADME Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global In Vivo and In Vitro DMPK and ADME Revenue Market Share by Type (2020-2025)
Table 25. Global In Vivo and In Vitro DMPK and ADME Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global In Vivo and In Vitro DMPK and ADME Revenue Market Share by Type (2026-2031)
Table 27. Global In Vivo and In Vitro DMPK and ADME Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global In Vivo and In Vitro DMPK and ADME Revenue Market Share by Application (2020-2025)
Table 29. Global In Vivo and In Vitro DMPK and ADME Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global In Vivo and In Vitro DMPK and ADME Revenue Market Share by Application (2026-2031)
Table 31. North America In Vivo and In Vitro DMPK and ADME Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America In Vivo and In Vitro DMPK and ADME Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America In Vivo and In Vitro DMPK and ADME Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe In Vivo and In Vitro DMPK and ADME Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe In Vivo and In Vitro DMPK and ADME Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe In Vivo and In Vitro DMPK and ADME Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America In Vivo and In Vitro DMPK and ADME Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America In Vivo and In Vitro DMPK and ADME Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America In Vivo and In Vitro DMPK and ADME Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Size by Country (2026-2031) & (US$ Million)
Table 46. Charles River Company Details
Table 47. Charles River Business Overview
Table 48. Charles River In Vivo and In Vitro DMPK and ADME Product
Table 49. Charles River Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 50. Charles River Recent Development
Table 51. Labcorp Company Details
Table 52. Labcorp Business Overview
Table 53. Labcorp In Vivo and In Vitro DMPK and ADME Product
Table 54. Labcorp Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 55. Labcorp Recent Development
Table 56. ICON Company Details
Table 57. ICON Business Overview
Table 58. ICON In Vivo and In Vitro DMPK and ADME Product
Table 59. ICON Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 60. ICON Recent Development
Table 61. Syneos Health Company Details
Table 62. Syneos Health Business Overview
Table 63. Syneos Health In Vivo and In Vitro DMPK and ADME Product
Table 64. Syneos Health Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 65. Syneos Health Recent Development
Table 66. Envigo Company Details
Table 67. Envigo Business Overview
Table 68. Envigo In Vivo and In Vitro DMPK and ADME Product
Table 69. Envigo Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 70. Envigo Recent Development
Table 71. Curia Company Details
Table 72. Curia Business Overview
Table 73. Curia In Vivo and In Vitro DMPK and ADME Product
Table 74. Curia Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 75. Curia Recent Development
Table 76. Evotec Company Details
Table 77. Evotec Business Overview
Table 78. Evotec In Vivo and In Vitro DMPK and ADME Product
Table 79. Evotec Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 80. Evotec Recent Development
Table 81. Bioduro-Sundia Company Details
Table 82. Bioduro-Sundia Business Overview
Table 83. Bioduro-Sundia In Vivo and In Vitro DMPK and ADME Product
Table 84. Bioduro-Sundia Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 85. Bioduro-Sundia Recent Development
Table 86. Lonza Company Details
Table 87. Lonza Business Overview
Table 88. Lonza In Vivo and In Vitro DMPK and ADME Product
Table 89. Lonza Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 90. Lonza Recent Development
Table 91. WuXi AppTec Company Details
Table 92. WuXi AppTec Business Overview
Table 93. WuXi AppTec In Vivo and In Vitro DMPK and ADME Product
Table 94. WuXi AppTec Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 95. WuXi AppTec Recent Development
Table 96. IQVIA Company Details
Table 97. IQVIA Business Overview
Table 98. IQVIA In Vivo and In Vitro DMPK and ADME Product
Table 99. IQVIA Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 100. IQVIA Recent Development
Table 101. Tecan Group Company Details
Table 102. Tecan Group Business Overview
Table 103. Tecan Group In Vivo and In Vitro DMPK and ADME Product
Table 104. Tecan Group Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 105. Tecan Group Recent Development
Table 106. Pharmaron Company Details
Table 107. Pharmaron Business Overview
Table 108. Pharmaron In Vivo and In Vitro DMPK and ADME Product
Table 109. Pharmaron Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 110. Pharmaron Recent Development
Table 111. Shanghai Medicilon Company Details
Table 112. Shanghai Medicilon Business Overview
Table 113. Shanghai Medicilon In Vivo and In Vitro DMPK and ADME Product
Table 114. Shanghai Medicilon Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 115. Shanghai Medicilon Recent Development
Table 116. ChemPartner Company Details
Table 117. ChemPartner Business Overview
Table 118. ChemPartner In Vivo and In Vitro DMPK and ADME Product
Table 119. ChemPartner Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 120. ChemPartner Recent Development
Table 121. Joinn Laboratories Company Details
Table 122. Joinn Laboratories Business Overview
Table 123. Joinn Laboratories In Vivo and In Vitro DMPK and ADME Product
Table 124. Joinn Laboratories Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 125. Joinn Laboratories Recent Development
Table 126. RTI International Company Details
Table 127. RTI International Business Overview
Table 128. RTI International In Vivo and In Vitro DMPK and ADME Product
Table 129. RTI International Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 130. RTI International Recent Development
Table 131. Eurofins Scientific Company Details
Table 132. Eurofins Scientific Business Overview
Table 133. Eurofins Scientific In Vivo and In Vitro DMPK and ADME Product
Table 134. Eurofins Scientific Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 135. Eurofins Scientific Recent Development
Table 136. Aragen Life Sciences Company Details
Table 137. Aragen Life Sciences Business Overview
Table 138. Aragen Life Sciences In Vivo and In Vitro DMPK and ADME Product
Table 139. Aragen Life Sciences Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 140. Aragen Life Sciences Recent Development
Table 141. Sai Life Sciences Company Details
Table 142. Sai Life Sciences Business Overview
Table 143. Sai Life Sciences In Vivo and In Vitro DMPK and ADME Product
Table 144. Sai Life Sciences Revenue in In Vivo and In Vitro DMPK and ADME Business (2020-2025) & (US$ Million)
Table 145. Sai Life Sciences Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report


List of Figures
Figure 1. In Vivo and In Vitro DMPK and ADME Picture
Figure 2. Global In Vivo and In Vitro DMPK and ADME Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In Vivo and In Vitro DMPK and ADME Market Share by Type: 2024 VS 2031
Figure 4. Small Molecules Features
Figure 5. Biologics Features
Figure 6. Global In Vivo and In Vitro DMPK and ADME Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global In Vivo and In Vitro DMPK and ADME Market Share by Application: 2024 VS 2031
Figure 8. Biopharmaceutical Companies Case Studies
Figure 9. Government and Academic Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. In Vivo and In Vitro DMPK and ADME Report Years Considered
Figure 12. Global In Vivo and In Vitro DMPK and ADME Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global In Vivo and In Vitro DMPK and ADME Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global In Vivo and In Vitro DMPK and ADME Market Share by Region: 2024 VS 2031
Figure 15. Global In Vivo and In Vitro DMPK and ADME Market Share by Players in 2024
Figure 16. Global Top In Vivo and In Vitro DMPK and ADME Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo and In Vitro DMPK and ADME as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by In Vivo and In Vitro DMPK and ADME Revenue in 2024
Figure 18. North America In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America In Vivo and In Vitro DMPK and ADME Market Share by Country (2020-2031)
Figure 20. United States In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe In Vivo and In Vitro DMPK and ADME Market Share by Country (2020-2031)
Figure 24. Germany In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific In Vivo and In Vitro DMPK and ADME Market Share by Region (2020-2031)
Figure 32. China In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America In Vivo and In Vitro DMPK and ADME Market Share by Country (2020-2031)
Figure 40. Mexico In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa In Vivo and In Vitro DMPK and ADME Market Share by Country (2020-2031)
Figure 44. Turkey In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE In Vivo and In Vitro DMPK and ADME Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Charles River Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 48. Labcorp Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 49. ICON Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 50. Syneos Health Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 51. Envigo Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 52. Curia Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 53. Evotec Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 54. Bioduro-Sundia Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 55. Lonza Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 56. WuXi AppTec Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 57. IQVIA Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 58. Tecan Group Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 59. Pharmaron Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 60. Shanghai Medicilon Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 61. ChemPartner Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 62. Joinn Laboratories Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 63. RTI International Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 64. Eurofins Scientific Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 65. Aragen Life Sciences Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 66. Sai Life Sciences Revenue Growth Rate in In Vivo and In Vitro DMPK and ADME Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit